Axial Spondyloarthritis
Axial spondyloarthritis (AS) is a form of inflammatory arthritis that primarily affects the spine and pelvis, leading to pain and stiffness in the back and hips, especially in the morning or after periods of inactivity.
Axial Spondyloarthritis: EAST-1 Trial
We are investigating a new treatment that targets ERAP inhibition for individuals with axial spondyloarthritis. The goal is to see if this approach improves symptoms compared to standard care.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Rheumatology
Heverlee, Belgium
Universitair Ziekenhuis Gent
Rheumatology
Ledeberg, Belgium
St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr
Rheumazentrum
Herne, Germany
Sponsor: Grey Wolf Therapeutics Limited
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.